UMediC Group Berhad

KLSE:UMC Voorraadrapport

Marktkapitalisatie: RM 226.2m

UMediC Group Berhad Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Taw Lim

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO3.6yrs
Eigendom CEO5.1%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur3.1yrs

Recente managementupdates

Recent updates

UMediC Group Berhad's (KLSE:UMC) Returns On Capital Not Reflecting Well On The Business

Nov 11
UMediC Group Berhad's (KLSE:UMC) Returns On Capital Not Reflecting Well On The Business

UMediC Group Berhad (KLSE:UMC) Hasn't Managed To Accelerate Its Returns

Aug 05
UMediC Group Berhad (KLSE:UMC) Hasn't Managed To Accelerate Its Returns

We Think You Should Be Aware Of Some Concerning Factors In UMediC Group Berhad's (KLSE:UMC) Earnings

Jun 17
We Think You Should Be Aware Of Some Concerning Factors In UMediC Group Berhad's (KLSE:UMC) Earnings

UMediC Group Berhad's (KLSE:UMC) Earnings Are Of Questionable Quality

Dec 18
UMediC Group Berhad's (KLSE:UMC) Earnings Are Of Questionable Quality

Revenue Downgrade: Here's What Analysts Forecast For UMediC Group Berhad (KLSE:UMC)

Dec 12
Revenue Downgrade: Here's What Analysts Forecast For UMediC Group Berhad (KLSE:UMC)

Some Investors May Be Worried About UMediC Group Berhad's (KLSE:UMC) Returns On Capital

Aug 11
Some Investors May Be Worried About UMediC Group Berhad's (KLSE:UMC) Returns On Capital

Robust Earnings May Not Tell The Whole Story For UMediC Group Berhad (KLSE:UMC)

Mar 13
Robust Earnings May Not Tell The Whole Story For UMediC Group Berhad (KLSE:UMC)

Is There An Opportunity With UMediC Group Berhad's (KLSE:UMC) 21% Undervaluation?

Nov 25
Is There An Opportunity With UMediC Group Berhad's (KLSE:UMC) 21% Undervaluation?

Analyse CEO-vergoeding

Hoe is Taw Lim's beloning veranderd ten opzichte van UMediC Group Berhad's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jul 31 2024n/an/a

RM 9m

Apr 30 2024n/an/a

RM 9m

Jan 31 2024n/an/a

RM 10m

Oct 31 2023n/an/a

RM 10m

Jul 31 2023n/an/a

RM 10m

Apr 30 2023n/an/a

RM 8m

Jan 31 2023n/an/a

RM 7m

Oct 31 2022n/an/a

RM 6m

Jul 31 2022RM 363kRM 228k

RM 6m

Jul 31 2021RM 891kRM 178k

RM 5m

Compensatie versus markt: Er zijn onvoldoende gegevens om vast te stellen of de totale vergoeding van Taw redelijk is in vergelijking met bedrijven van vergelijkbare omvang in de MY markt.

Compensatie versus inkomsten: De vergoeding van Taw is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Taw Lim (45 yo)

3.6yrs

Tenure

RM 363,000

Compensatie

Mr. Taw Seong Lim serves as the Chief Executive Officer at UMediC Group Berhad and its an Executive Director since April 22, 2021. He began his career in 2002 with UMediC (formerly known as UWC Healthcar...

Bestuursleden

NaamPositieTenureCompensatieEigendom
Taw Lim
CEO & Executive Director3.6yrsRM 363.00k5.11%
MYR 11.6m
Sze Ng
Legal & Corporate Adviser and Alternate Director1.7yrsgeen gegevens0.080%
MYR 181.5k
Chai Ng
Non-Independent Non-Executive Chairman3.1yrsRM 61.00k5.46%
MYR 12.3m
Yee Lee
Independent Non-Executive Director3.1yrsRM 30.50k0.080%
MYR 181.5k
Pakirisamy Baskaran
Independent Non-Executive Director3.1yrsRM 30.50k0.080%
MYR 181.5k
Chye Tan
Independent Non-Executive Director3.1yrsRM 30.50k0.080%
MYR 181.5k
Keng Teh
Non Executive Independent Director1.1yrsgeen gegevensgeen gegevens

3.1yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van UMC wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.1 jaar).